Evidence map›Paper›PMID 33110777›Full record

ReviewJournal of family medicine and primary care2020

Coronavirus disease 2019 (COVID-19): Insights into the recent trends and the role of the primary care in diabetic patients.

Aliyah M Marghalani, Ibtihal M Althumali, Lujain M Yousef, Miad A Alharthi, Zainab S Alahmari, Ahmed M Kabel

Abstract readReview
In one paragraph

Review in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aliyah M MarghalaniPharm D, College of Pharmacy, Taif University, Taif, KSA.
Ibtihal M AlthumaliPharm D, College of Pharmacy, Taif University, Taif, KSA.
Lujain M YousefPharm D, College of Pharmacy, Taif University, Taif, KSA.
Miad A AlharthiPharm D, College of Pharmacy, Taif University, Taif, KSA.
Zainab S AlahmariPharm D, College of Pharmacy, Taif University, Taif, KSA.
Ahmed M KabelDepartment of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, KSA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diseases with viral etiology continue to emerge in the last years and may represent serious problems that affect various aspects of life. Coronaviruses are a large family of RNA viruses that cause illness affecting the respiratory tract ranging from common cold to severe respiratory distress syndrome. In the last weeks of 2019, enormous cases of unexplained pneumonia were reported in China. Few days later, a novel type of coronavirus was identified as the causative agent of these cases and the disease was named as coronavirus disease 2019 (COVID-19) by the World Health Organization. The disease was rapidly spreading in China and all over the world and now it is considered as pandemic catastrophe. It can be transmitted from animals to human and from human to human. Diabetes mellitus may represent a potential risk factor for the development of COVID-19, possibly due to the relative state of immunosuppression frequently encountered in diabetic patients. This review sheds light on COVID-19 based on the currently available data with reference to the role of the primary care in diabetic patients.

Indexed as

CoronavirusCOVID-19diabetes mellitusprimary carerespiratory distress syndrome

Identifiers

PMID33110777
PMCPMC7586637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.